If it’s Subsidized, Get it Authorized: New Restrictions on the Sale and Use of PHI for Marketing Purposes Under HIPAA’s Omnibus Rule.
When is a patient’s authorization required to use his or her protected health information for marketing purposes? The answer to this question has changed, and so has HIPAA’s definition of “marketing.” Join Angela Rust, an associate with Hinshaw & Culbertson, as she explains the analysis step by step, and how it has changed from the rule HHS previously proposed to the new Omnibus Rule. Join us to learn more about how subsidized treatment and health care operations communications will require patient authorization for the first time since HIPAA became law, and practice applying the new regulations to practical examples.
